• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

RespireRX Pharma Presenting at MicroCap Conference Today

June 16, 2017

 (Photo Credit - Marcum MicroCap)


James S. Manuso, Ph.D., the CEO of RespireRX Pharmaceuticals Inc. (OTC:RSPI), will be reviewing the company's Phase-3 ready dronabinol (synthetic Delta-9-THC) medicine for the treatment of obstructive sleep apnea and more at the Marcum MicroCap Conference today




As we covered in the article linked above, dronabinol is a lab-made replica of the delta-9-THC cannabinoid that is naturally occurring in marijuana. Since the '80's, dronabinol capsules have been approved by the FDA for treating appetite loss associated with AIDS as well as for nausea and vomiting associated with chemotherapy cancer treatment.


RespireRX plans to get FDA approval for obstructive sleep apnea, a.k.a. OSA. This afflicts millions of americans and could be a huge market.


When & Where


The presentation will be at 10:00 AM EST on June 16th. For those attending the Marcum MicroCap event, presentations will be held at the Grand Hyatt Hotel in Manhattan. For those interested in watching this presentation that are unable to attend the event, Dr. Manuso's presentation will be available by live webcast streaming online and archived for 90 days.


To access the webcast, go to http://wsw.com/webcast/marcum5/rspi or visit the RespireRx website at www.respirerx.com, click on the same link on the home page, or, click on the Investors tab and follow the links to this press release and click the webcast link.




Be sure to subscribe to one or more of our free newsletters so you never miss an important update. If you haven't already, connect with The Daily Marijuana Observer on FacebookTwitter, and Instagram



Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.